🇺🇸 FDA
Pipeline program

PF-07915503, PF-07915503, PF-07915503, Etrasimod Arginine Blue, PF-07915503

C5041018

Phase 2 small_molecule active

Quick answer

PF-07915503, PF-07915503, PF-07915503, Etrasimod Arginine Blue, PF-07915503 for Ulcerative Colitis is a Phase 2 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer Ireland Pharmaceuticals Unlimited Company
Indication
Ulcerative Colitis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials